Publications

Detailed Information

Effect of a peroxisome proliferator-activated receptor gamma sumoylation mutant on neointimal formation after balloon injury in rats

DC Field Value Language
dc.contributor.authorLim, Soo-
dc.contributor.authorAhn, Byung Yong-
dc.contributor.authorChung, Sung Soo-
dc.contributor.authorPark, Ho Seon-
dc.contributor.authorKim, Min-
dc.contributor.authorLee, In Kyu-
dc.contributor.authorChoi, Soo Joon-
dc.contributor.authorCho, Young Min-
dc.contributor.authorPark, Kyong Soo-
dc.contributor.authorLee, Hong Kyu-
dc.contributor.authorChung, Chin Ha-
dc.contributor.authorLee, Sang-Won-
dc.contributor.authorChoi, Sung Hee-
dc.contributor.authorCho, Bong Jun-
dc.date.accessioned2012-05-24T07:27:11Z-
dc.date.available2012-05-24T07:27:11Z-
dc.date.issued2009-10-
dc.identifier.citationATHEROSCLEROSIS; Vol.206 2; 411-417ko_KR
dc.identifier.issn0021-9150-
dc.identifier.urihttps://hdl.handle.net/10371/76441-
dc.description.abstractPeroxisome proliferator-activated receptor gamma(PPAR gamma) is a nuclear receptor regulating inflammation, atherosclerosis, insulin sensitivity and adipogenesis. Recently, it has been discovered that modification by the small ubiquitin-like modifier (SUMO) plays an important role in PPAR gamma activity. In the present study, we investigated the effect of sumoylation on the antiatherogenic property of PPAR gamma. PPAR gamma-K107R sumoylation mutant, PPAR gamma-wild type (WT) and control genes were transfected on vascular smooth muscle cells (VSMCs) to compare their effect on the proliferation and migration. Adenoviral vectors expressing the PPAR gamma-K107R, PPAR gamma-WT or control gene were delivered into the carotid arteries of rats after balloon injury. The PPAR gamma-K107R increased the transcriptional activity of peroxisome proliferator response element (PPRE) and had a more potent transcriptional repression activity on the inducible nitric oxide synthase (iNOS) promoter as compared to the other sumoylation mutants or WT. PPAR gamma-K107R or WT gene transfer inhibited VSMCs proliferation and migration to a greater extent than the control. The PPAR gamma-K107R had more potent activity than PPAR gamma-WT in this regard. PPAR gamma-K107R or WT transfer showed a significantly lower intima-media ratio (IMR) than the control after balloon injury in rats. Again, the delivery of the PPAR gamma-K107R decreased IMR further compared to PPAR gamma-WT. In addition, the PPAR gamma-K107R transfer showed a lower proliferation index and a higher apoptotic index than PPAR gamma-WT. In conclusion, the PPAR gamma sumoylation mutant K107R strongly inhibited VSMCs proliferation and migration, sustained apoptosis, and reduced neointimal formation after balloon injury. These results indicate that desumoylation at K107 in PPAR gamma might play an important role against atherosclerosis. (C) 2009 Elsevier Ireland Ltd. All rights reserved.ko_KR
dc.language.isoenko_KR
dc.publisherELSEVIER IRELAND LTDko_KR
dc.subjectPPAR gammako_KR
dc.subjectNeointimako_KR
dc.subjectApoptosisko_KR
dc.subjectProliferationko_KR
dc.subjectVascular smooth muscleko_KR
dc.subjectSumoylationko_KR
dc.titleEffect of a peroxisome proliferator-activated receptor gamma sumoylation mutant on neointimal formation after balloon injury in ratsko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor임수-
dc.contributor.AlternativeAuthor안병용-
dc.contributor.AlternativeAuthor정성수-
dc.contributor.AlternativeAuthor박호선-
dc.contributor.AlternativeAuthor조봉준-
dc.contributor.AlternativeAuthor김민-
dc.contributor.AlternativeAuthor최성희-
dc.contributor.AlternativeAuthor이인규-
dc.contributor.AlternativeAuthor이상원-
dc.contributor.AlternativeAuthor최수준-
dc.contributor.AlternativeAuthor정진하-
dc.contributor.AlternativeAuthor조영민-
dc.contributor.AlternativeAuthor이홍규-
dc.contributor.AlternativeAuthor박경수-
dc.identifier.doi10.1016/j.atherosclerosis.2009.02.031-
dc.citation.journaltitleATHEROSCLEROSIS-
dc.description.citedreferenceHome PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394-
dc.description.citedreferenceNissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761-
dc.description.citedreferenceChoi SJ, 2006, J BIOL CHEM, V281, P30669, DOI 10.1074/jbc.M604033200-
dc.description.citedreferenceLim S, 2006, ARTERIOSCL THROM VAS, V26, P808, DOI 10.1161/01.ATV.0000204634.26163.a7-
dc.description.citedreferenceSamaha FF, 2006, ARTERIOSCL THROM VAS, V26, P624, DOI 10.1161/01.ATV.0000200136.567196.30-
dc.description.citedreferenceDormandy JA, 2005, LANCET, V366, P1279-
dc.description.citedreferencePascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988-
dc.description.citedreferenceHay RT, 2005, MOL CELL, V18, P1-
dc.description.citedreferenceAli AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735-
dc.description.citedreferenceBruemmer D, 2005, INT J OBESITY, V29, pS26, DOI 10.1038/sj.ijo.0802910-
dc.description.citedreferenceChoi D, 2004, DIABETES CARE, V27, P2654-
dc.description.citedreferenceYamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x-
dc.description.citedreferenceOhshima T, 2004, J BIOL CHEM, V279, P29551, DOI 10.1074/jbc.M403866200-
dc.description.citedreferencePhillips JW, 2003, CIRCULATION, V108, P1994, DOI 10.1161/01.CIR.0000092886.52404.50-
dc.description.citedreferenceRangwala SM, 2003, DEV CELL, V5, P657-
dc.description.citedreferenceHong HK, 2003, DIABETES RES CLIN PR, V62, P1, DOI 10.1016/S0168-8227(03)00142-6-
dc.description.citedreferenceBruemmer D, 2003, CIRC RES, V93, pE38, DOI 10.1161/01.RES.0000088344.15288.E6-
dc.description.citedreferenceBlanquart C, 2003, J STEROID BIOCHEM, V85, P267, DOI 10.1016/S0960-0760(03)00214-0-
dc.description.citedreferenceHirano Y, 2003, J BIOL CHEM, V278, P16809, DOI 10.1074/jbc.M212448200-
dc.description.citedreferenceMUDALIAR S, 2003, ENDOCR PRACT, V9, P406-
dc.description.citedreferenceKim J, 2002, J BIOL CHEM, V277, P38037, DOI 10.1074/jbc.M207235200-
dc.description.citedreferenceEloranta JJ, 2002, J BIOL CHEM, V277, P30798, DOI 10.1074/jbc.M202780200-
dc.description.citedreferenceBishop-Bailey D, 2002, CIRC RES, V91, P210, DOI 10.1161/01.RES.0000029080.15742.85-
dc.description.citedreferenceWilson VG, 2001, EXP CELL RES, V271, P57-
dc.description.citedreferenceRodriguez MS, 2001, J BIOL CHEM, V276, P12654-
dc.description.citedreferenceCollins AR, 2001, ARTERIOSCL THROM VAS, V21, P365-
dc.description.citedreferenceHsueh WA, 2001, DIABETES CARE, V24, P392-
dc.description.citedreferenceMiwa Y, 2000, MOL PHARMACOL, V58, P837-
dc.description.citedreferenceLi AC, 2000, J CLIN INVEST, V106, P523-
dc.description.citedreferenceLaw RE, 2000, CIRCULATION, V101, P1311-
dc.description.citedreferenceMelchior F, 2000, ANNU REV CELL DEV BI, V16, P591-
dc.description.citedreferenceMarx N, 1998, CIRC RES, V83, P1097-
dc.description.citedreferenceTontonoz P, 1998, CELL, V93, P241-
dc.description.citedreferenceANSARI B, 1993, J PATHOL, V170, P1-
dc.description.tc8-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share